Drug Search Results
More Filters [+]

Cinhyaluronate sodium

Alternative Names: cinhyaluronate sodium, si-614, si614, si 614
Latest Update: 2023-05-16
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: No Mechanism

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Seikagaku
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Cinhyaluronate sodium

Countries in Clinic: United States

Active Clinical Trial Count: 1

Highest Development Phases

Phase 3: Dry Eye Disease|Dry Eye Syndromes|Keratoconjunctivitis Sicca

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

SIDE

P3

Completed

Dry Eye Syndromes|Keratoconjunctivitis Sicca|Dry Eye Disease

2023-03-02

38%

Recent News Events

Date

Type

Title